Pure Global

The Effect of Ultrasonography-guided Fascial Plane Blocks in Breast Cancer Surgery Patients - Trial NCT06419504

Access comprehensive clinical trial information for NCT06419504 through Pure Global AI's free database. This phase not specified trial is sponsored by Antalya Training and Research Hospital and is currently Recruiting. The study focuses on Breast Cancer. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06419504
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06419504
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effect of Ultrasonography-guided Fascial Plane Blocks in Breast Cancer Surgery Patients
The Effect of Ultrasonography-guided Pectoserratus Plane Block, Erector Spina Plane Block and Serratus Anterior Plane Block on Postoperative Opioid Consumption, Recovery Quality and Chronic Pain in Breast Cancer Surgery Patients

Study Focus

Breast Cancer

SAP block group

Observational

other

Sponsor & Location

Antalya Training and Research Hospital

Antalya, Turkey

Timeline & Enrollment

N/A

May 17, 2024

Nov 15, 2024

96 participants

Primary Outcome

postoperative opioid consumption

Summary

The aim of this study was to evaluate the efficacy of serratus anterior plane (SAP) block,
 pectoserratus plane (PECS II) block, and erector spinae plane (ESP) block on postoperative
 acute pain, quality of recovery and chronic pain in breast cancer surgery patients.

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

ClinicalTrials.gov

NCT06419504

Non-Device Trial